SELLAS Life Sciences Group (SLS) Current Deferred Revenue: 2011-2020
Historic Current Deferred Revenue for SELLAS Life Sciences Group (SLS) over the last 2 years, with Dec 2020 value amounting to $5.6 million.
- SELLAS Life Sciences Group's Current Deferred Revenue was N/A to $900,000 in Q1 2021 from the same period last year, while for Mar 2021 it was $900,000, marking a year-over-year change of. This contributed to the annual value of $5.6 million for FY2020, which is N/A change from last year.
- According to the latest figures from FY2020, SELLAS Life Sciences Group's Current Deferred Revenue is $5.6 million, which was up 586.27% from $816,000 recorded in FY2011.
- SELLAS Life Sciences Group's Current Deferred Revenue's 5-year high stood at $5.6 million during FY2020, with a 5-year trough of $5.6 million in FY2020.
- Its 1-year average for Current Deferred Revenue is $5.6 million, with a median of $5.6 million in 2020.